CCA
ETRM

Conestoga Capital Advisors’s EnteroMedics Inc. ETRM Stock Holding History

Conestoga Capital Advisors’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10
Closed -$16K – 136
2014
Q2 		$16K Hold
10
– – ﹤0.01% 129
2014
Q1 		$18K Hold
10
– – ﹤0.01% 134
2013
Q4 		$20K Hold
10
– – ﹤0.01% 137
2013
Q3 		$12K Hold
10
– – ﹤0.01% 131
2013
Q2 		$11K Buy
+10
New +$10.6K ﹤0.01% 126

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Conestoga Capital Advisors's ETRM Position: Q3 2014 in Review

Conestoga Capital Advisors sold out of EnteroMedics Inc. (ETRM) in Q3 2014, closing a stake of 10 shares — an estimated $16K sold.

Conestoga Capital Advisors first reported a position in ETRM in Q2 2013 and held it in 5 quarters. The position peaked at $20K in Q4 2013. 49 funds tracked by Wall St. Rank hold ETRM as of Q3 2014.

  • Conestoga Capital Advisors reported no remaining EnteroMedics Inc. position as of Q3 2014 after selling out during the quarter.
  • Conestoga Capital Advisors sold 10 EnteroMedics Inc. shares in Q3 2014, an estimated $16K.
  • Conestoga Capital Advisors first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 5 quarters.
  • Conestoga Capital Advisors's EnteroMedics Inc. position peaked at $20K in Q4 2013.
  • 49 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q3 2014.

Based on Conestoga Capital Advisors's 13F filing for Q3 2014, filed 7 Nov 2014.